APA aipamena

Bonig, H., Wundes, A., Chang, K., Lucas, S., & Papayannopoulou, T. (2008). Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. American Society of Hematology.

Chicago Style aipamena

Bonig, Halvard, Annette Wundes, Kai-Hsin Chang, Sylvia Lucas, and Thalia Papayannopoulou. Increased Numbers of Circulating Hematopoietic Stem/progenitor Cells Are Chronically Maintained in Patients Treated With the CD49d Blocking Antibody Natalizumab. American Society of Hematology, 2008.

MLA aipamena

Bonig, Halvard, et al. Increased Numbers of Circulating Hematopoietic Stem/progenitor Cells Are Chronically Maintained in Patients Treated With the CD49d Blocking Antibody Natalizumab. American Society of Hematology, 2008.